HIGHLINE WEALTH PARTNERS LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 2042654
SHERMAN OAKS, CA
Position in TEVA
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,558
+$173 QoQ
Shares Held
46
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#638
of 671 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $231,239 across 10 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
351 | $190,182 | |
| 2 | VTRS |
Viatris Inc
|
750 | $11,910 | |
| 3 | ZTS |
Zoetis Inc.
|
118 | $8,479 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
274 | $6,743 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
296 | $4,744 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
27 | $4,550 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
46 | $1,558 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
98 | $1,420 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,558 | 46 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,385 | 46 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $1,435 | 46 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $929 | 46 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,765 | 165 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,536 | 165 | Shares | Sole | 2025-04-17 | |
| No filing history on record for this holder in this stock. | ||||||